GNPX insider buying & filings

GNPXGenprex, Inc.

—

9 insider filings on record.
None of them an open-market buy in the last year.

Last Form 4 Feb 27 · scanned 3h ago

No price data yet — the yfinance scanner hasn't produced bars for GNPX.

AI brief · from the filings on this pagePro

The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.

Short % float

Pro

Congress

▸ Disclosures lag trades by 30–45 days.

4 disclosures12 mo

MemberTradeAmountOwnerTradedFiled

Tim MooreR· House · NC-14Budget · Financial Servicestraded 5 Feb · filed 20 Feb · selfBought$1K–$15Kself5 Feb224d ago20 Feb209d ago

Tim MooreR· House · NC-14Budget · Financial Servicestraded 18 Dec 2025 · filed 7 Jan · selfBought$1K–$15Kself18 Dec 2025273d ago7 Jan253d ago

The record

newest first

DateTypeInsiderOf stakeShares @ priceValue

Feb 27TAXConfer Ryan M.President, CEO and CFOdirect9,330 @ $2.00$18.7K

Feb 27TAXBerger Mark StanleyChief Medical Officerdirect7,168 @ $2.00$14.3K

Dec 23GRANTMoreno Toscano Jose AntonioDirectordirect9,000 sh—

Dec 23GRANTLongnecker Brent MDirectordirect9,000 sh—

Dec 23GRANTWilson William R Jr.Directordirect9,000 sh—

The file stays open

▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice